All data are based on the daily closing price as of July 1, 2025
h

Humedix

200670.KQ
41.47 USD
-0.65
-1.54%

Overview

Last close
41.47 usd
Market cap
427.93M usd
52 week high
44.40 usd
52 week low
18.18 usd
Target price
41.76 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
5.3464
Price/Book Value
2.4633
Enterprise Value
344.13M usd
EV/Revenue
2.8948
EV/EBITDA
7.6564

Key financials

Revenue TTM
82.04M usd
Gross Profit TTM
32.57M usd
EBITDA TTM
20.89M usd
Earnings per Share
N/A usd
Dividend
0.49 usd
Total assets
180.56M usd
Net debt
N/A usd

About

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    200670.KQ
  • Exchange
    KQ
  • Isin
    KR7200670008
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seongnam-si
  • Web site
    https://humedix.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top